FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma

Medical and Pediatric Oncology

Volumn 41, Issue 1, 2003, Pages 30-35

  Spitz, Ruediger ^a   Hero, Barbara ^a   Ernestus, Karen ^a   Berthold, Frank ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Chromosomal deletion; Chromosomal imbalance; FISH; Ploidy

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 1P; CHROMOSOME 2; CHROMOSOME 3Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISOMY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; NEUROBLASTOMA; NUMERICAL CHROMOSOME ABERRATION; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TETRASOMY; TRISOMY; CHILD; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 3; COHORT ANALYSIS; DNA PROBE; FEMALE; GENETICS; GERMANY; HUMAN CHROMOSOME; MALE; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR RECURRENCE;

MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; COHORT STUDIES; DNA PROBES; FEMALE; GERMANY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0037734164     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10313     Document Type: Article

References (31)

1. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-1124.
2. Maris JM, White PS, Beltinger CP, et al. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 1995;15:4664-4669.
3. Hallstensson K, Thulin S, Aburatani H, et al. Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma. Eur J Cancer 1997;33:1966-1970.
4. Ejeskar K, Aburatani H, Abrahamsson J, et al. Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene. Br J Cancer 1998;77:1787-1791.
5. Lastowska M, Nacheva E, McGuckin A, et al. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosomes Cancer 1997;18:162-169.
6. Brinkschmidt C, Christiansen H, Terpe HJ, et al. Comparative genomic hybridization (CGH) analysis of neuroblastomas-an important methodological approach in paediatric tumour pathology. J Pathol 1997;181:394-400.
7. Van Gele M, Van Roy N, Jauch A, et al. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer 1997;33:1979-1982.
8. Vandesompele J, Van Roy N, Van Gele M, et al. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 1998;23:141-152.
9. Guo C, White PS, Hogarty MD, et al. Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas. Med Pediatr Oncol 2000;35:544-546.
10. Maris JM, Guo C, White PS, et al. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma. Med Pediatr Oncol 2001;36:24-27.
11. Ambros PF, Ambros IM, SIOP Europe Neuroblastoma Pathology, Biology, and Bone Marrow Group. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 2001;37:492-504.
12. Takita J, Hayashi Y, Kohno T, et al. Allelotype of neuroblastoma. Oncogene 1995;11:1829-1834.
13. Takeda O, Handa M, Uehara T, et al. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas. Br J Cancer 1996;74:1620-1626.
14. Luttikhuis ME, Powell JE, Rees SA, et al. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer 2001;85:531-537.
15. Plantaz D, Vandesompele J, Van Roy N, et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 2001;91:680-686.
16. Breen CJ, O'Meara A, McDermott M, et al. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000;120:44-49.
17. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 1989;86:3753-3757.
18. Weith A, Martinsson T, Cziepluch C, et al. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer 1989;1:159-166.
19. Takayama H, Suzuki T, Mugishima H, et al. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 1992;7:1185-1189.
20. White PS, Kaufman BA, Marshall HN, et al. Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma. Genes Chromosomes Cancer 1993;7:102-108.
21. Spitz R, Hero B, Ernestus K, et al. FISH analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 2002;34:299-305.
22. Guo C, White PS, Weiss MJ, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 1999;18:4948-4957.
23. Kaneko Y, Kobayashi H, Maseki N, et al. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants. Int J Cancer 1999;80:54-59.
24. Kaneko Y, Knudson AG. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 2000;29:89-95.
25. Ambros PF, Brodeur GM. 2000. Concept of tumorigenesis and regression. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, editors. Neuroblastoma. Amsterdam: Elsevier Science. 2000; Chapter 3:p 21-23.
26. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996;334:225-230.
27. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-1116.
28. Spitz R, Hero B, Ernestus K, et al. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clin Cancer Res (in press).
29. Kaneko Y, Kanda N, Maseki N, et al. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 1987;47:311-318.
30. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 1991;9:581-591.
31. Ladenstein R, Ambros IM, Potschger U, et al. Prognostic significance of DNA ditetraploidy in neuroblastoma. Med Pediatr Oncol 2001;36:83-92.